Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 28, 2022 - The FDA approved Sun Pharma’s Aspruzyo Sprinkle (ranolazine), for the treatment of chronic angina.
Download PDF
Return to publications
